Cite
MLA Citation
David Griffith et al.. “218. A Phase 1 Study of the Single-Dose Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor Xeruborbactam Administered as the Isobutyryloxymethyl Oral Prodrug to Healthy Adult Subjects.” Open forum infectious diseases, vol. 9, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100174901370.0x00000a